BVMF: DASA3
- Last Close 11.33
- Sector Healthcare
- Industry Diagnostics & Research
- Investment Style Small Growth
- Day Range 10.83 – 11.44
- Year Range 6.57 – 25.21
- Market Cap 8.2157 Bil
- Volume / Avg 377,800.0 / 522,791.8
- Price / Sales 0.50
- Price / Book 1.20
- Forward Div Yield 0.86%
- Trailing Div Yield 0.91%
Morningstar‘s Stock Analysis DASA3
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile DASA3
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
Diagnosticos da America SA
BVMF: DASA3
| Lexagene Holdings Inc
XTSX: LXG.H
| PZ CORMAY SA
XWAR: CRM
| Fleury SA
BVMF: FLRY3
| |
Price
| — | 0.11 | — | — |
Currency
| — | CAD | — | — |
Change
| — | −$0.03 (19.23%) | — | — |
Market Cap
| — | 14.77 Mil | — | — |
Industry
| Diagnostics & Research | Medical Devices | Scientific & Technical Instruments | Diagnostics & Research |
Sector
|
Healthcare
|
Healthcare
|
Technology
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Diagnosticos da America SA Stock
Yes. DASA3 has a forward dividend yield of 0.86%.
See
DASA3’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
DASA3’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
DASA3’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare DASA3’s historical performance against its industry peers and the overall market.